세계의 지카바이러스 검사 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별(핵산 증폭 검사(NAAT), 혈청학적 검사), 지역별, 경쟁별(2020-2030년)
Zika Virus Testing Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing), By Region & Competition, 2020-2030F
상품코드:1743990
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 지카바이러스 검사 시장은 2024년에 1억 6,223만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 6.42%로 성장할 것으로 예측됩니다.
이 시장은 모기가 매개하는 병원체인 지카바이러스를 검출하는 데 사용되는 진단 기술에 초점을 두고 있으며, 특히 감염된 산모로부터 태어난 유아의 선천성 이상과 같은 심각한 건강 결과와 관련하여 알려져 있습니다. 검사 방법은 PCR과 같은 분자진단, 혈청학적 분석, 신속한 진단 테스트 등이 있습니다. 이러한 솔루션에 대한 수요는, 지역적인 유행 시에 강해져, 자주 신속한 공중 위생 대응이 요구됩니다. 지카열로 인한 임산부와 신생아의 건강 영향에 대한 인식 제고 및 감염병 대비를 강화하는 세계의 노력이 시장의 꾸준한 확대에 기여하고 있습니다. CDC 같은 기관은 특히 바이러스가 가장 높은 위험을 초래하는 임신 초기 조기 발견의 중요성을 강조하고 있습니다. 이 분야는, 새로운 매개 감염병의 위협에 대처하기 위해서, 서베일런스, 공중 위생 인프라, 진단 기술 혁신이 진화함에 따라, 계속적인 성장이 전망되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
1억 6,223만 달러
시장 규모(2030년)
2억 3,375만 달러
CAGR(2025-2030년)
6.42%
급성장 부문
핵산 증폭 검사(NAAT)
최대 시장
북미
시장 성장 촉진요인
지카바이러스 발생
주요 시장 과제
다른 감염과의 경쟁
주요 시장 동향
세계 모니터링 네트워크
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 지카바이러스 검사 시장 전망
시장 규모 및 예측
금액별
시장 점유율 및 예측
검사 유형별(핵산 증폭 검사(NAAT), 혈청학적 검사)
지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
기업별(2024년)
검사 유형 시장 맵
검사 유형별
지역별
제6장 북미의 지카바이러스 검사 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 지카바이러스 검사 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 지카바이러스 검사 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
일본
인도
한국
호주
제9장 남미의 지카바이러스 검사 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 지카바이러스 검사 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
아랍에미리트(UAE)
사우디아라비아
남아프리카
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향 및 발전
합병 및 인수
검사 유형 개발
최근 동향
제13장 Porter's Five Forces 분석
제14장 PESTEL 분석
제15장 경쟁 구도
Quest Diagnostics, Inc.
Chembio Diagnostic Systems, Inc.
Biocan Diagnostics, Inc.
DiaSorin SpA
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
SD Biosensors, Inc.
제16장 전략적 제안
제17장 기업 소개 및 면책사항
AJY
영문 목차
영문목차
The Global Zika Virus Testing Market was valued at USD 162.23 million in 2024 and is expected to grow at a CAGR of 6.42% through 2030. This market focuses on diagnostic technologies used to detect the Zika virus, a mosquito-borne pathogen known for its association with severe health outcomes, especially congenital defects in infants born to infected mothers. Testing methods include molecular diagnostics such as PCR, serological assays, and rapid diagnostic tests. Demand for these solutions intensifies during regional outbreaks, often prompting swift public health responses. Rising awareness of Zika's impact on maternal and neonatal health and global efforts to enhance infectious disease preparedness contribute to steady market expansion. Institutions like the CDC highlight the critical importance of early detection, particularly during early pregnancy, when the virus poses the highest risk. The sector is poised for continued growth as surveillance, public health infrastructure, and diagnostic innovation evolve to address emerging vector-borne threats.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 162.23 Million
Market Size 2030
USD 233.75 Million
CAGR 2025-2030
6.42%
Fastest Growing Segment
Nucleic Acid Amplification Testing (NAAT)
Largest Market
North America
Key Market Drivers
Zika Virus Outbreaks
Zika virus outbreaks play a pivotal role in driving the global demand for Zika virus testing. These outbreaks, typically concentrated in areas prone to mosquito-borne illnesses, create urgent public health challenges, triggering widespread diagnostic initiatives. The rapid transmission of the virus via the Aedes mosquito and its association with severe complications like microcephaly in newborns heighten the necessity for early and accurate detection. According to the CDC, first-trimester infections carry the highest risk, with 8% of affected pregnancies in U.S. regions leading to related birth defects. In response, health agencies deploy robust testing strategies aimed at curbing the spread and safeguarding at-risk populations. These efforts, often coordinated through government and international partnerships, lead to temporary surges in testing volumes and drive investment in diagnostics. The market's responsiveness to such health crises ensures its ongoing relevance and integration into emergency preparedness frameworks globally.
Key Market Challenges
Competition from Other Infectious Diseases
The Zika Virus Testing Market faces considerable challenges due to competing priorities in infectious disease management. Resources, funding, and healthcare attention are often directed toward higher-profile or more widespread diseases such as HIV/AIDS, tuberculosis, malaria, or emerging threats like COVID-19. This competition can limit the allocation of critical infrastructure and support for Zika-specific testing, slowing innovation, limiting deployment, and reducing public awareness. As healthcare systems balance multiple disease burdens, Zika testing may receive less focus unless an outbreak occurs, making sustained growth difficult. Ensuring Zika remains on the global health agenda requires coordinated efforts among governments, health organizations, and diagnostics companies to maintain testing readiness and infrastructure.
Key Market Trends
Global Surveillance Networks
A major trend shaping the Global Zika Virus Testing Market is the development and expansion of global surveillance networks. These collaborative systems integrate data collection, diagnostic standardization, and real-time information exchange to monitor the spread of the Zika virus. By fostering international cooperation, these networks enable timely identification of high-risk zones and facilitate proactive deployment of testing resources. Key components include harmonized testing protocols, shared insights on mosquito vectors, and integration with public health strategies. These surveillance systems not only enhance the responsiveness of testing operations but also influence diagnostic demand and guide investment in research. The strengthening of such global monitoring infrastructure supports early detection and containment, reinforcing the importance of diagnostic tools in managing vector-borne disease outbreaks.
Key Market Players
Quest Diagnostics, Inc.
Chembio Diagnostic Systems, Inc.
Biocan Diagnostics, Inc.
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
SD Biosensors, Inc.
Report Scope:
In this report, the Global Zika Virus Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Zika Virus Testing Market, By Test Type:
Nucleic Acid Amplification Testing (NAAT)
Serological Testing
Zika Virus Testing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Zika Virus Testing Market.
Available Customizations:
Global Zika Virus Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Zika Virus Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing)
5.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.3. By Company (2024)
5.3. Test Type Market Map
5.3.1. By Test Type
5.3.2. By Region
6. North America Zika Virus Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Zika Virus Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.2. Canada Zika Virus Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.3. Mexico Zika Virus Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
7. Europe Zika Virus Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Zika Virus Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.2. France Zika Virus Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.3. United Kingdom Zika Virus Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.4. Italy Zika Virus Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.5. Spain Zika Virus Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
8. Asia-Pacific Zika Virus Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Zika Virus Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.2. Japan Zika Virus Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.3. India Zika Virus Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.4. South Korea Zika Virus Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.5. Australia Zika Virus Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
9. South America Zika Virus Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Zika Virus Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.2. Argentina Zika Virus Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.3. Colombia Zika Virus Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
10. Middle East and Africa Zika Virus Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type
10.2.2. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Zika Virus Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.2. Saudi Arabia Zika Virus Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test Type
10.3.3. South Africa Zika Virus Testing Market Outlook
